Phase II study of selumetinib (sel) versus temozolomide (TMZ) in gnaq/Gna11 (Gq/11) mutant (mut) uveal melanoma (UM).
暂无分享，去创建一个
G. Linette | J. Wolchok | J. Sosman | G. Schwartz | P. Chapman | M. Albertini | P. Flynn | K. Panageas | M. Milhem | Takami Sato | T. Gajewski | J. Lutzky | R. Kudchadkar | C. Lao | A. Joshua | M. Dickson | D. Lawson | F. Quevedo | Daniel Paucar